Search our website

Conferences

VBI Vaccines to Present New Preclinical Data for its GBM Immunotherapy, VBI-1901, at SITC 2017
November 10th, 2017
VBI Vaccines Hepatitis B Data Selected as Presidential Poster of Distinction at The Liver Meeting® 2017
October 17th, 2017
VBI Vaccines to Present at September 2017 Investor Conferences
September 12th, 2017
VBI Vaccines to Present New Preclinical Data for its GBM Immunotherapy, VBI-1901, at the Immuno-Oncology Summit
August 28th, 2017
VBI Vaccines Announces Positive Interim Data from Phase 1 Study of Preventative CMV Vaccine
July 27th, 2017
VBI Vaccines Announces Phase 3 Clinical Program for Sci-B-Vac® Hepatitis B Vaccine
July 11th, 2017
VBI Vaccines to Present at Jefferies 2017 Global Healthcare Conference
June 5th, 2017
VBI Vaccines to Present Updates on Multiple Programs at the World Vaccine Congress
April 5th, 2017
VBI Vaccines to Present at the Immunization and Vaccine Summit
December 5th, 2016
VBI Vaccines to Present at the Society of Neuro-Oncology Annual Meeting
November 10th, 2016
VBI Vaccines to Present Zika Vaccine Program Poster at the Keystone Symposia on Translational Vaccinology for Global Health
October 27th, 2016
VBI Vaccines to Present at the World Vaccine Congress Europe
October 5th, 2016
VBI Vaccines to Present at the Ladenburg Thalmann Healthcare Conference
September 26th, 2016
VBI Vaccines to Present at the Rodman & Renshaw Annual Global Investment Conference
September 7th, 2016
VBI Vaccines to Present at the Vaccine Congress
September 1st, 2016
VBI Vaccines to Present at the Immuno-Oncology Summit
August 29th, 2016
VBI Vaccines to Ring the Nasdaq Stock Market Opening Bell
July 14th, 2016
VBI Vaccines to Present at the Virus-Like Particle and Nano-Particle Vaccines Conference
June 17th, 2016
VBI Vaccines to Host Hepatitis B Key Opinion Leader Meeting
June 10th, 2016
VBI Vaccines to Present at the BIO International Convention
June 3rd, 2016

Sign-up for Our Distribution List to Receive the Latest News and Updates from VBI

Sign Up NowArrow
Go top